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Background: Comprehensive annotation of transcripts expressed in a given tissue is a critical step towards the
understanding of regulatory and functional pathways that shape the transcriptome.
Results: Here, we reconstructed a cumulative transcriptome of the human prefrontal cortex (PFC) based on
approximately 300 million strand-specific RNA sequence (RNA-seq) reads collected at different stages of postnatal
development. We find that more than 50% of reconstructed transcripts represent novel transcriptome elements,
including 8,343 novel exons and exon extensions of annotated coding genes, 11,217 novel antisense transcripts
and 29,541 novel intergenic transcripts or their fragments showing canonical features of long non-coding RNAs
(lncRNAs). Our analysis further led to a surprising discovery of a novel class of bidirectional promoters (NBiPs) driving
divergent transcription of mRNA and novel lncRNA pairs and displaying a distinct set of sequence and epigenetic
features. In contrast to known bidirectional and unidirectional promoters, NBiPs are strongly associated with genes
involved in neuronal functions and regulated by neuron-associated transcription factors.
Conclusions: Taken together, our results demonstrate that large portions of the human transcriptome remain
uncharacterized. The distinct sequence and epigenetic features of NBiPs, as well as their specific association with
neuronal genes, further suggest existence of regulatory pathways specific to the human brain.
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The advent of high-throughput sequencing has ushered
in a new chapter in transcriptome studies, allowing se-
quencing and mapping of all transcripts present in a
given sample, independent of the existing genome anno-
tation. The application of high-throughput sequencing
to the characterization of human transcriptomes in dif-
ferent tissues and developmental stages has already
revealed thousands of novel transcripts and novel tran-
script isoforms [1], and resulted in the recognition of
long non-coding RNAs (lncRNAs) as a permanent fea-
ture of the human and mammalian transcriptome, as
well as the identification of novel transcript types, such* Correspondence: huhaiyang@picb.ac.cn; khaitovich@eva.mpg.de
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unless otherwise stated.as piwi-interacting RNA and circular RNA [2-6]. Tran-
script annotation has been further aided by the introduc-
tion of strand-specific RNA-sequencing (RNA-seq)
protocols allowing identification of sense and antisense
transcripts [7,8], as well as specific protocols designed to
identify the 5′-end and 3′-end of transcripts: deepCAGE
and 3P-Seq [9,10].
Despite considerable efforts, human transcriptome an-
notation remains incomplete. This is largely due to the
nature of the novel transcriptome elements: most of
lncRNAs and other non-canonical transcripts are ex-
pressed in a highly spatial- and temporally- specific
manner, i.e. their repertoires differ greatly among tissues,
cell types and ontogenetic stages [1,4]. Furthermore, ca-
nonical protein-coding genes have been shown to
undergo alternative splicing, and use alternative tran-
scription start and termination sites across tissues, cell
types and ontogenetic stages, further contributing toThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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both protein-coding and lncRNA transcripts are re-
ported to show the greatest heterogeneity in testis and
brain [12].
Correct and comprehensive identification of the tran-
scripts expressed in a given tissue is a critical step
towards reconstruction of regulatory and functional in-
teractions. For instance, regulatory network reconstruc-
tion relies on identification of transcription factor and
microRNA binding sites, which in turn require know-
ledge of the transcription start site position and 3′ un-
translated region (UTR) boundaries in a given sample.
Growing recognition of the regulatory roles played by
lncRNAs, which may act as cis- or trans- regulators of
other transcripts, further highlights the need for complete
characterization of the transcriptome as a prerequisite for
regulatory and functional network reconstruction. Many
lncRNAs are located in the proximity of protein-coding
genes, and are transcribed from certain types of regulatory
regions, further indicating their regulatory potential.
lncRNAs transcribed from enhancer regions upon cellular
membrane depolarization (eRNA) have been linked to the
elevated expression of neighboring genes in murine neural
cells [13]. Similarly, diverse populations of lncRNAs have
been shown to originate from known promoter regions
[14]. In human and murine embryonic stem cells (ESCs),
more than half of all expressed lncRNAs represented di-
vergent transcription from bidirectional promoters of
known protein-coding genes [15]. While in ESCs, these di-
vergent lncRNAs were associated with elevated expression
of the corresponding protein-coding genes, other studies
have reported negative regulation of protein-coding genes
by divergent lncRNA expression [16].
In this study we took advantage of a large strand-
specific RNA-seq dataset to characterize the transcrip-
tome of one of the most heterogeneous and complex
human tissues – human prefrontal cortex (PFC). Our
results demonstrate that systematic transcriptome char-
acterization not only reveals thousands of yet unanno-
tated transcripts, but also allowed us to discover a novel
type of bidirectional promoters comprised of canonical
protein-coding gene and tissue-specific novel non-
coding transcript pairs. Most remarkably, these bidirec-
tional promoters represent a specific promoter category,
characterized by its own sequence and epigenetic signa-
ture and specifically associated with expression of neur-
onal genes.
Results
More than 40% of transcripts expressed in the human
brain are novel
To explore the dynamics of the human prefrontal cortex
polyA-plus transcriptome, we took advantage of strand-
specific high-throughput sequencing data collected inthe prefrontal cortex (PFC) of 14 human individuals with
an age range from 2 days to 98 years [17] (Additional file 1:
Table S1). These data contained an average of 21 million
100-nt-long reads per sample, with a total of 296 million
reads (Additional file 2: Table S2). To avoid limitations
imposed by transcriptome read mapping to the genome,
we first assembled transcripts de novo using the Trinity al-
gorithm [18]. Of the raw sequence reads, 96% were
retained after quality control and subsequently used in the
transcript assembly. The assembly resulted in 332,993
transcript contigs with an average length of 1,005 nt and
minimum length set to 300 nt. Of them, 307,543 (92.4%)
could be unambiguously and uniquely aligned to the hu-
man reference genome using GMAP [19]. Merging con-
tigs that overlapped with each other on the human
genome resulted in 92,705 contig clusters. The total
length of these assembled transcripts was 94,989,683 nt.
Of them, 61,650,777 nt (64.9%) overlapped with human
annotated transcripts (Ensembl gene annotation, version
64 [20]) covering 61% of all annotated exons, while the
remaining 36,938,906 nt (35.1%) represented as yet unan-
notated portions of the human brain transcriptome.
Among the unannotated transcripts 4,124,023 nt (4.2%)
originated from novel elements of annotated genes, such
as novel exons and novel exon extensions; 3,877,147 nt
(3.6%) from the antisense strand of annotated genes; and
28,937,736 nt (29.7%) from novel intergenic transcripts
(Figure 1a). Accordingly, of the 92,705 assembled contig
clusters, 51,948 (56%) overlapped with at least one
annotated transcript, while the remaining 40,758 (44%)
originated from gene antisense and intergenic regions
(Figure 1b). In terms of transcriptome read counts, and
reflecting the expression level of the transcripts, annotated
transcripts accounted for 81% of all transcriptome reads,
novel elements of annotated genes and intergenic tran-
scripts – for 9% each, and antisense transcripts – for the
remaining 1% (Figure 1c).
Notably, our analysis also revealed potential gaps, not
only in the human genome annotation, but also in the
human genome itself. We found 368 human transcript
contigs that could not be mapped to the reference hu-
man genome (hg19), but could be aligned unambigu-
ously to at least one of the following non-human
reference genomes: chimpanzee, orangutan, macaque or
mouse genomes. Cumulatively these contigs cover
146,035 bases and include 12 putative protein-coding
genes and 101 putative novel exons from another 10 an-
notated protein-coding genes.
Annotated human transcripts contain numerous novel
elements
Among the 51,948 assembled contig clusters that were lo-
cated within annotated transcripts, 3,699 clusters, com-
posed of 12,822 contigs, contained transcript elements not
Figure 1 Annotated and novel portions of the human PFC transcriptome. (a), (b), (c) The proportion of four transcript types – annotated
transcripts (orange), novel elements of annotated transcripts (blue), antisense transcripts (green), and novel intergenic transcripts (purple) – with
respect to the total transcriptome length, transcript count and expression level, respectively. (d) Categories of novel elements of annotated
transcripts detected in the human PFC transcriptome. Black and grey boxes indicate annotated exons and UTRs, white boxes represent novel
transcript elements. The “Support” column shows the percentage of novel transcript isoforms confirmed by Oases and Cufflinks transcriptome
assembly algorithms, and additionally supported by H3K4me3 modification peaks and transcript polyA tails (see Methods).
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cluded: 972 novel internal exons located in 754 protein-
coding genes; 926 and 1,121 novel donor and acceptor
splice sites containing canonical splicing signals located in
1,687 protein-coding genes; as well as 1,224 and 4,100
novel 5′UTR and 3′UTR extensions with a length of at
least 100 nt and located in 1,952 protein-coding genes.
9.2% of these novel transcript elements were highly
expressed (top 25% quantile of the annotated protein-
coding transcripts in the corresponding gene), while
35.8% were moderately expressed (within the 75% quantile
of the annotated protein-coding transcripts in the corre-
sponding gene). Besides protein-coding genes, 267 novel
exons, 354 splice boundaries and 1,106 5′/3′UTR ex-
tensions were found in annotated pseudogenes, lncRNAs
and processed transcripts from 1,531 contig clusters
(Figure 1d). 75.6% of these novel elements could be vali-
dated by the other transcript assembly algorithms, Oases
[21] or Cufflinks [22], as well as by the presence of
H3K4me3 modification peaks, commonly associated with
active promoters, or sequence reads corresponding to
transcripts’ polyA tails (see Additional file 3: Supplementary
Methods).Novel transcripts show properties of long non-coding RNA
Among the 92,705 contig clusters identified in our data,
40,758 had no overlap with genome annotation (Ensembl
version 64) (Additional file 4: Supplementary data 1).
Some of these transcripts showed a moderate expression:
using expression of protein-coding genes as a reference,
3.1% of contig clusters were highly expressed (top 25%
quantile of all annotated protein-coding transcripts) and
26.2% - moderately expressed (within the 75% quantile of
all annotated protein-coding transcripts). Based on a cod-
ing potential estimation using the CPC algorithm [23],
99% of these transcripts have negative coding potential
score and, therefore, may represent novel long non-coding
RNAs (lncRNAs) or novel lncRNA fragments (Figure 2a).
Besides negative coding potential scores, novel contigs
clusters displayed other features characteristic of annotated
lncRNAs. Specifically, contig clusters containing multiple
exons displayed canonical donor (68%) and acceptor (64%)
splice sites (Figure 2c). Further, 30% of the novel contigs
clusters featured H3K4me3 modification peaks within 2 kb
region from their 5′end (Figure 2d, simulations, p < 0.01,
Additional file 3: Supplementary Methods). Consistent
with the polyA enrichment procedure used during
Figure 2 Properties of novel transcripts. (a) Distributions of coding potential scores estimated for novel transcripts (red) and annotated protein-
coding genes (PCG, gray) using CPC (Coding Potential Calculator). Negative scores indicate low coding potential. (b) Cumulative distribution of exon
sequence conservation levels estimated using PhastCons scores based on 17 vertebrate species’ genomes. The colors indicate novel transcripts (red),
random intergenic regions (black), annotated lncRNAs (blue), pseudogenes (pink), UTR exons (purple) and protein-coding exons (green). (c) Nucleotide
composition at and around the splice sites (positions 11-12) of annotated protein-coding genes (PCG, upper panel) and novel transcripts (bottom
panel). (d) H3K4me3 modification profiles at the promoter region of annotated protein-coding genes (PCG, upper panel) and novel transcripts (bottom
panel). Transcription start site (TSS) position of novel transcripts was estimated using deepCAGE data from brain tissues. (e) Nucleotide composition
around the transcript termination sites (TTS) of annotated protein-coding genes (PCG, upper panel) and novel transcripts (bottom panel). (f) Tissue
specificity of expression for annotated protein-coding genes (PCG), annotated lncRNA (lncRNA) and novel transcripts (novel), calculated using Body
Map data. (g) Cellular localization (cytosol to nucleus expression level [RPKM] ratio) of annotated protein-coding genes (PCG), annotated lncRNA
(lncRNA) and novel transcripts (novel).
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clusters contained detectable polyA tails within a 2 kb re-
gion from their 3′end (Figure 2e, simulations, p < 0.01,
Supplementary Methods). The novel contig clusters
identified in our study were significantly more con-
served at the DNA sequence level among 17 vertebrate
species when compared to randomly selected intergenic
regions or annotated human lncRNAs (Kolmogorov–
Smirnov test, p < 0.0001) (Figure 2b). In agreement with
previous studies reporting a high tissue-specificity for
lncRNA expression [4], among the 31,006 novel contig
clusters that could be quantified in the Human Body
map data (mean expression > 0.1 RPKM across tissues),
89% were expressed in a tissue-specific (38%) or tissue-
selective manner (51%) (Figure 2f). Furthermore, similar
to known lncRNAs, novel transcripts were preferentially
localized in the nucleus (Figure 2g). Taken together,
these features indicate that identified contig clusters
may, in many cases, represent as yet unannotated hu-
man lncRNAs or lncRNA fragments.
The RNA-seq data we used to identify novel transcripts
represents a human PFC developmental time-series. Ac-
cordingly, 20% of the transcript clusters representingFigure 3 Relationship between sense and antisense transcript expres
overlapping gene pairs. Black and gray boxes represent annotated protein-
antisense transcript elements. (b), (e) Distribution of Pearson correlation co
transcripts in tail-to-tail (panel b) or head-to-head (panel e) gene pairs (red
development. (c), (f) Difference between the kernel density distribution of
pairs’ correlation and the control ones. Red line indicates the overlapping p
by randomly subsampling the same number of control pairs as overlappingnovel lncRNAs showed significant expression level change
with age (polynomial regression, permutation p < 0.01, q <
0.02 see Methods). Notably, the majority of these
transcripts were highly expressed in early development
(Fisher’s exact test, p < 0.001 after Bonferroni correc-
tion, Additional file 5: Figure S1 and Additional file 6:
Table S3).
Properties of antisense transcripts
Use of a strand-specific sequencing protocol allowed us
to evaluate the expression of transcripts originating from
the antisense strand of annotated protein-coding gene
regions. Among the 92,705 contig clusters assembled in
this study, 13,218 were located on the antisense strand
relative to annotated protein-coding gene regions. Of
these, 11,217 were completely unannotated and 2,001
overlapped partially with annotated genes located on the
same strand. Taken together, these antisense contig clus-
ters resulted in 1479 annotated and 870 novel sense/
antisense overlapping coding gene pairs (see Methods,
Figure 3a and d, Additional file 7: Table S4).
One notable feature of the novel antisense contig clus-
ters was their distributions within antisense regions: whilesion. (a), (d) Schematic representations of tail-to-tail and head-to-head
coding and untranslated exons, red and blue boxes indicates novel
efficients calculated based on expression of sense and antisense
), and control non-overlapping gene pairs (black), during postnatal PFC
the overlapping tail-to-tail (panel c) or head-to-head (panel f) gene
airs, while the gray lines represent 100 simulation results, generated
pairs.
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and 3′ region of the sense gene, the novel antisense contig
clusters were distributed much more uniformly (Additional
file 5: Figure S2). To test whether the novel antisense con-
tig clusters may represent long extensions of annotated
transcripts located nearby, we searched for reads corre-
sponding to splicing junctions connecting antisense contig
clusters and neighboring genes in our RNA-seq data
(Additional file 3: Supplementary Methods). Indeed, we
identified 185 such connections, 136 of them representing
3′ extensions (tail-to-tail gene pairs) and 49 representing
5′ extension (head-to-head gene pairs), while only 16
would be expected by chance (simulation test, p < 0.001,
Additional file 7: Table S4). Notably, 3′ extensions verified
by splice junctions were also distributed broadly within
antisense regions, with the longest reaching the 5′-end of
the sense gene.
What is the influence of these antisense transcripts on
gene expression of sense/antisense gene pairs? Previous
studies have indicated that the majority of identified
sense/antisense gene pairs are positively correlated, while
inversely correlated pairs also exist [8,24-26]. To test the
effect of antisense transcription on expression of the
sense genes we took advantage of the age-related changes
in expression of sense and antisense transcripts during hu-
man brain development, which could be documented in
our dataset. In agreement with previous studies, we ob-
served a significant excess of both positive and negative
correlation for 1,330 tail-to-tail annotated and novel
sense/antisense gene pairs compared to equidistant non-
overlapping gene pairs (Figure 3b and c, Additional file 5:
Figure S3, Additional file 7: Table S4). For 1,152 sense/
antisense gene pairs with overlapping 5′ regions (head-to-
head gene pairs), only an excess of positive correlations
was observed (Figure 3e and f, Additional file 5: Figure S4,
Additional file 7: Table S4). Positively correlated expres-
sion of head-to-head gene pairs may reflect shared open
chromatin structure and regulation. More interestingly,
the observations of positively and inversely correlated
expression patterns from tail-to-tail pairs appears to
represent a more complicated regulatory phenomenon
that includes agonistic interactions between sense and
antisense transcription, such as the previously pro-
posed spatial collision of transcription and splicing
machineries [27-30].
Novel upstream antisense lncRNAs expressed in the PFC
originate from a new class of bidirectional promoters
Previous studies have shown that the majority of the
novel transcripts located outside of annotated gene re-
gions, both sense and antisense, may represent as yet
unannotated extensions of known genes [31]. Indeed,
among 39,364 novel contig clusters with expression
greater than 0.1 RPKM, 14,235 (36.2%) were locatedwithin 4 kb from annotated transcript boundaries (simu-
lations, p < 0.04, Supplementary data 1). Based on the
DNA strand, and relative position with respect to the
nearest annotated transcript region, these 14,235 novel
transcripts could be further classified into four categor-
ies: upstream-sense (1,323 or 9.3%), downstream-sense
(6,965 or 48.9%), upstream-antisense (2,964 or 20.7%),
and downstream-antisense (2,983 or 21.1%). We found a
significant excess of positive correlations between the
expression of transcripts represented by novel contig
clusters and the expression of nearby protein-coding
genes for the upstream-sense, downstream-sense and
upstream-antisense categories (Figure 4a, b and c). No
significant correlation signal was found for the downstream-
antisense category (Figure 4d).
While novel contig clusters located on the sense
strand may represent 5′ and 3′ extensions of known
genes, transcripts originating from the antisense strand
must have an independent origin. Indeed, there is no
correlation between the expression of annotated genes
and nearby antisense transcripts located downstream. By
contrast, a significant excess of positive correlations be-
tween annotated genes and upstream-antisense tran-
scripts may indicate shared regulation, presumably at as
yet unannotated bidirectional promoters. Indeed, a sig-
nature of divergent transcription characteristic of bidir-
ectional promotes can be observed for the upstream-
antisense transcripts and the corresponding annotated
genes, using public human brain deepCAGE tag data
from FANTOM4 [9]. The divergent transcription was
strong for all upstream-antisense novel transcript/gene
pairs, and particularly pronounced for the 273 upstream-
antisense novel transcript/gene pairs that showed a sig-
nificant positive correlation in the PFC time-series data
(Pearson correlation, p < 0.05 after Benjamini-Hochberg
correction), compared to other promoters annotated as
unidirectional (Fisher’s exact test, p < 0.0001, Additional
file 5: Figure S5, Additional file 8: Table S5, Additional file 4:
Supplementary data 1).
Novel upstream antisense lncRNAs expressed in PFC are
linked to neural function
Functional analysis of the protein-coding genes associ-
ated with the 273 novel upstream-antisense transcripts
revealed a strong and significant enrichment in 21 Gene
Ontology (GO) functional terms after redundancy reduc-
tion [32], including neuronal functions such as “memory”,
“generation of neurons” and “regulation of synaptic trans-
mission” (hypergeometric test, p < 0.05 after Benjamini-
Hochberg correction, Figure 4e, Additional file 9: Table S6).
Consistently, the 273 genes are preferentially expressed in
neurons, as gauged from H3K4me3 modification data col-
lected in neurons and non-neuronal cells in the human
PFC [33] (Simulation test, p < 0.0001, Figure 4f), and
Figure 4 Properties of genes associated with novel upstream-antisense lncRNAs. (a), (b), (c), (d) Distribution of Pearson correlation coefficients
calculated based on the expression of protein-coding genes and nearest novel lncRNAs (red curve). The gray curves show the average correlation
coefficient distribution based on 200 permutations of neighboring novel lncRNAs and protein-coding gene relationships. The gray shaded areas show
standard error of the curve estimates. The distributions are shown for four possible genomic configurations of lncRNA relative to protein-protein-
coding genes: upstream-sense, downstream sense, upstream-antisense and downstream-antisense. (e) GO terms enriched in 273 protein-coding genes
associated with upstream-antisense novel lncRNAs. The node color indicates the GO term’s enrichment p-value, the node size is proportional to the
GO term’s annotated gene number. Dashed rectangle indicates GO terms associated with neuronal functions. (f) Expression specificity of 273 protein-
coding genes associated with upstream-antisense novel lncRNAs, calculated based on H3K4me3 modification from neurons and non-neural cells of
human PFC. The red bar shows neuron/non-neuron cells ratio for the 273 genes, the gray bars represent the ratio distribution calculated by 1,000
permutations of 273 randomly selected expressed genes. (g) Expression specificity of 273 protein-coding genes associated with upstream-antisense
novel lncRNAs calculated based on cell type specific expression data from mouse neocortex. The bars show Fisher’s test odds ratio with 95%
confidence interval for enrichment of the 273 genes among mouse orthologs preferentially expressed in oligodentrocytes (blue), astrocytes (green)
and neurons (red). The numbers show Fisher’s test p-values. (h), (i) The TFBS density profiles of two enriched TFs, ETF (panel h) and ZF5 (panel i), within
NBiPs. The red and blue curves show observed TFBS density distributions at sense and antisense strands. The pink and the light blue curves represent
TFBS density distributions calculated by 1,000 permutations of TFBS prediction across dinucleotide shuffled NBiP sequences.
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mouse brain [34] (Fisher’s exact test, p < 0.0001 after
Bonferroni correction, Figure 4g, see Methods). By con-
trast, protein-coding genes associated with novel tran-
scripts from the other three categories did not show any
significant functional enrichment. More surprisingly,
known bidirectional promoters (KBiPs), either consisting
of two protein-coding genes, or protein-coding gene and
known lncRNA pairs, expressed in the human PFCshowed no significant enrichment in neural functions. In-
stead, these genes were significantly underrepresented in
neuronal functions, but overrepresented in biological pro-
cesses related to RNA processing, DNA repair, DNA
metabolic process, and ribonucleoprotein complex bio-
genesis (Additional file 10: Table S7). Similarly, annotated
genes transcribed from annotated unidirectional pro-
moters (UniPs), and showing no evidence of upstream
antisense expression in our data, were not enriched in
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lated to signal transducer activity and receptor activity
(Additional file 11: Table S8). Thus, the bidirectional pro-
moters identified in our study (novel bidirectional pro-
moters or NBiPs) may represent a separate promoter
category that differs from both UniPs and KBiPs and par-
ticular to genes expressed in neurons and/or associated
with neuronal functions.
Novel bidirectional promoters are enriched in
transcription factors associated with neurons
The unique functional features of NBiPs prompted us to
explore transcription factors that may regulate this pro-
moter type. Several transcription factors that are prefer-
entially associated with bidirectional promoters have
been identified by previous studies [35,36]. Comparing
transcription factor binding site (TFBSs) density within
2 kb of NBiPs and KBiPs revealed 10 TFBSs that corres-
pond to 11 transcription factors (TFs) enriched in
NBiPs, and 6 TFBSs corresponding to 8 TFs enriched in
KBiPs (Fisher’s exact test, p < 0.05 after Benjamini-
Hochberg correction & odds ratio > 1.3, Additional file 12:
Table S9 and Additional file 13: Table S10). The associ-
ation between enriched TFs and NBiPs was further con-
firmed for five TFs by the significant correlation of their
expression profiles and the expression profiles of the pre-
dicted target transcripts originating from the NBiPs
(permutations, p < 0.05, Additional file 12: Table S9). Fur-
thermore, for two of the five enriched and correlated TFs,
significant peaks of TFBS density profiles were detected in
the center of the NBiP regions (Figure 4h,i). Notably, with
respect to function, TFs enriched in NBiPs were sig-
nificantly co-cited with the terms “neural” or “neuron”
(CoCiter [37], p < 0.01, Additional file 12: Table S9). By
contrast, TFs enriched in KBiPs showed no such associ-
ation (CoCiter, p > 0.2, Additional file 13: Table S10).
Thus, NBiPs may represent an integral part of a regulatory
mechanism specific to a set of neuronal genes and involv-
ing specific neuron-related TFs.
Novel bidirectional promoters show unique DNA
sequence and epigenetic features
The unique functional and regulatory features of NBiPs
might suggest a specific sequence and epigenetic signa-
ture for this promoter type. Indeed, compared with
UniPs and KBiPs, NBiPs show significant differences
with respect to all common sequence and epigenetic fea-
tures: GC content, regulatory potential, sequence con-
servation, H3K4me3 modification profile, and DNA
methylation status. Specifically, NBiPs have a higher GC
content and higher regulatory potential, measured as a
Regulatory Potential (RP) Score [38], than both UniPs and
KBiPs (Kolmogorov-Smirnov test, p < 0.0001; Figure 5a,b).
Further, NBiPs are more conserved at the DNA sequencelevel than KBiPs (Kolmogorov–Smirnov test, p < 0.001),
while both types of bidirectional promoters are more con-
served than UniPs (Kolmogorov-Smirnov test, p < 0.0001,
Figure 5c). H3K4me3 modification density, measured in
the human PFC neurons [33], is higher at NBiPs than
KBiPs indicating promoter activity (Wilcoxon test, p <
0.001). Further, H3K4me3 modification density was
greater at both types of bidirectional promoters compared
to UniPs (Wilcoxon test, p < 0.0001; Figure 5d). Notably,
besides the overall H3K4me3 modification density differ-
ences, the shape of H3K4me3 modification profiles differs
among the three promoter types (Figure 5e). Specifically,
UniPs show starkly asymmetric H3K4me3 modification
profiles with much of the modification density located
downstream of the protein-coding gene transcriptional
start site (TSS). By contrast, the shape of H3K4me3 modi-
fication profile is more symmetric relative to the TSS for
both NBiPs and KBiPs, with the most symmetric signa-
tures observed at KBiPs. This difference in H3K4me3
modification signature could be reproduced using other
H3K4me3 modification datasets obtained from human
and rhesus macaque PFC samples, as well as HeLa cells
[39-41] (Additional file 5: Figure S6). By contrast, the in-
put control showed no significant differences in shape and
density for H3K4me3 modification profiles among the
three promoter types (Additional file 5: Figure S7). Lastly,
DNA methylation levels measured in the human PFC [39]
also differed among the three promoter types: DNA
methylation levels are high at UniPs, intermediate at
KBiPs and the lowest at NBiPs (Wilcoxon test, p < 0.0001;
Figure 5f). KBiPs are comprised of two types of bidirec-
tional promoters: one formed by two protein-coding genes
(pcKBips, n = 806), and the other – by a protein-coding
gene and known lncRNA pair (lncKBips, n = 359). Do the
aforementioned sequence and epigenetic features charac-
teristic of NBiPs also distinguish them from bidirectional
promoters containing known lncRNAs (lncKBips)? To an-
swer this, we directly compared the DNA sequence com-
position and epigenetic features of NBiPs and lncKBiPs.
Except for the shape of H3K4me3 modification profile,
there are significant differences between other features for
these two promoter types. Furthermore, the sequence and
epigenetic properties of lncKBiPs closely resembled those
of known bidirectional promoters formed by pairs of
protein-coding genes (pcKBiPs). Besides promoter fea-
tures, the effect of PABPN1 knockdown on lncRNA that
are associated with NBiPs differed from the effect seen for
known lncRNA and protein-coding genes associated with
lncKBiPs and pcKBiPs (Additional file 5: Figure S8). Thus,
in the brain, NBiPs formed by lncRNA represent a distinct
type of bidirectional promoter with characteristic struc-
tural and regulatory properties when compared to known
bidirectional promoters, including those containing
known lncRNA.
Figure 5 Sequence and epigenetic features of different promoter types. (a), (b) and (c) The cumulative distributions of GC content, Regulatory
Potential and sequence conservation for the three promoter types: UniPs (green), KBiPs (blue) and NBiPs (red). All measurements are based on a 2 kb
region surrounding the TSS. Promoter sequence conservation was calculated using PhastCons scores, based on 17 vertebrate species’ genomes.
Promoter Regulatory Potential was calculated using Regulatory Potential (RP) scores (see Methods). (d), (e) The density (panel d) and the shape (panel e)
of H3K4me3 modification profiles at each of the three promoter types. (f) DNA methylation profile at each of the three promoter types. (g) PABPN1
expression across human tissues calculated using Body Map data. (h), (i) The expression change distribution for different transcript types in a PABPN1
knockdown experiment. The positive values indicate expression upregulation following PABPN1 knockdown.
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Knowledge of the composition of the human prefrontal
cortex transcriptome is critical for studying the com-
plexity of RNA transcription and regulation, as well as
its impact on neuronal functions. Here, by applying a
strand-specific RNA sequencing procedure to different
stages of postnatal development, we have obtained one
of the most complete and dynamic pictures of thehuman prefrontal cortex transcriptome. Several interest-
ing observations have emerged.
First, despite the substantial efforts made towards hu-
man brain transcriptome characterization in previous
decades, more than 50% of PFC transcripts recon-
structed in our study represent novel transcriptome ele-
ments. These elements include novel exons and exon
extensions of annotated protein-coding and lncRNA
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tentially interesting feature of antisense transcripts
highlighted by our study is their length. While many of
the antisense transcripts found in our study represent as
yet unannotated extensions of the neighboring genes,
these extensions frequently stretch for hundreds of base
pairs, traversing the entire length of the sense genes. In
agreement with previous studies, these antisense tran-
scripts can display both negative and positive correlation
with expression of the sense genes [25].
Second, while most of the lncRNAs expressed in the
prefrontal cortex (39.8%) localize in close proximity
(<4 kb) to known protein-coding genes, one fraction of
these transcripts, the lncRNAs located upstream of the
protein-coding genes on the antisense strand, particu-
larly stands out. Specifically, these transcripts: (a) show a
significantly positive correlation with the expression of
the upstream protein-coding genes; (b) originate from a
specific class of bidirectional promoters showing unique
sequence and epigenetic features; (c) are highly enriched
upstream of genes that are expressed in neurons and in-
volved in neuronal functions; and (d) are enriched in
TFs shown to be linked to neurons.
Bidirectional promoters are a common feature of the
human genome, and have also been described in the
mouse and other species [42,43]. In humans, 10% of
protein-coding genes were annotated to originate from
bidirectional promoters [43]. Remarkably, genes prefer-
entially expressed in brain and involved in neural
functions were depleted at these known bidirectional
promoters [44]. This result was further confirmed in this
present study. By contrast, novel bidirectional promoters
showing divergent transcription of novel and potentially
brain-specific lncRNAs, are highly enriched in neuronal
genes. The novel bidirectional promoters identified in
our study are also distinct from both known bidirec-
tional promoters and unidirectional promoters with re-
spect to many aspects of sequence composition and
epigenetic features, including H3K4me3 chromatin mod-
ifications and DNA methylation. Thus, they may repre-
sent a novel promoter type specifically associated with
the expression of neuronal genes and regulated by a spe-
cific set of TFs. Intriguingly, TFs showing significant as-
sociation with this promoter type, include all three
methylation resistant TFs (AP-2 family, EGR family and
ZF5) representing three of the top four discriminatory
features used to predict methylation status of CpG
islands in the human brain [45]. This fact may explain
the unique DNA methylation signature of the NBiPs ob-
served in our study.
Expression of lncRNAs from bidirectional promoters
has been previously shown in many human cell types,
including human embryonic stem cells (hESCs) where
>60% promoters might be bidirectional and associatedwith divergent lncRNAs [15]. Notably, even though we
find no significant overlap between bidirectional pro-
moters described in hESCs and NBiPs identified in this
study, in both cases expression of protein-coding genes
correlated positively with expression of divergent lncRNAs.
It is, however, unclear whether this positive correlation
represents a regulatory effect of lncRNAs, or a passive
consequence of the transcriptional activation of the diver-
gent protein-coding genes. Most human promoters bind
polymerase complexes in a bidirectional manner and are
therefore capable of initiating transcription in both direc-
tions [42]. Thus, we cannot exclude that the presence of
lncRNAs at the novel type of bidirectional promoters
identified in our study may represent a passive byproduct
of neuronal gene transcription from this specific promoter
type.
Transcripts expressed in the PFC, and more generally
in the brain, are characterized by extended 3′UTR re-
gions [12]. This phenomenon may in part be explained
by the low expression of PABPN1, a gene recently shown
to play a role in transcript processing [46,47] in brain
tissue (Figure 5g). Intriguingly, by reanalyzing data from
[48], we found that the expression of novel lncRNAs ori-
ginating from NBiPs was starkly increased in a PABPN1
knockdown experiment. Furthermore, this expression in-
crease was significantly greater than for other lncRNA
types (Figure 5h and i). This indicates that the strong
expression of lncRNAs originating from NBiPs in the
human PFC could be due to this general transcript pro-
cessing mechanism.
Conclusions
Taken together, our results demonstrate that large por-
tions of the human transcriptome remain uncharacter-
ized and even unknown. We further show that more
detailed transcriptome characterization may lead to the
identification of new types of regulatory elements, such as
a novel class of bidirectional promoters associated with
the expression of neuronal genes. Finally, our study con-
firms pervasive transcription of lncRNAs in the human
PFC, again raising the question of their functionality.
Methods
Quality evaluation of strand-specific sequencing
The RNA-Seq data from 14 human individuals with an
age range from 2 days to 98 years were downloaded
from [17]. To evaluate the correctness of strand specifi-
city of this dataset, total reads were mapped to the hu-
man genome (hg19) using PalMapper [49] (Additional
file 2: Table S2, Additional file 3: Supplementary methods).
Read distribution along sense/antisense strands was calcu-
lated based on protein-coding genes (PCG) defined by
Ensembl gene annotation (version 64) (Additional file 14:
Table S11). Note that within the Ensembl annotation, a
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strand or on different strands. To avoid erroneous count-
ing of sense and antisense reads, reads from overlapped
regions on the same strand were counted only once, while
reads from overlapped regions located on different strands
were excluded.
Strand-specific quality evaluation was done by: (1) check-
ing the expression correlation of protein-coding genes
between two strands within each sample; (2) examining
the sense/antisense ratio of the exon-spanning junction
reads that had built-in directionalities (Additional file 5:
Figure S9, Additional file 15: Table S12 and Additional
file 3: Supplementary Methods).
De novo transcript assembly
The quality of raw deep sequencing reads was first
assessed using the FASTX tool kit (http://hannonlab.
cshl.edu/fastx_toolkit/index.html). After removing low
quality reads (phred score < 20), raw reads from 14 hu-
man prefrontal cortex samples were combined, resulting
in a total of 284 million 100 nt strand-specific reads.
These reads were used as the input data for Trinity de
novo assembly. Trinity (version r2011-11-26) was down-
loaded from the Trinity homepage [18]. The assembly
parameters were chosen as follows: (–seqType fq –single –
CPU 80 –min_contig_length 150 –SS_lib_type F –bfly-
HeapSpace 260G). After removing the transcript contigs
with a length shorter than 300 nt, Trinity finally reported
332,993 transcript contigs with an average length of
1,005 nt and a minimum length of 300 nt. Besides Trinity,
the Cufflinks [22] and Oases [21] assembly algorithms
were applied to the same human PFC RNA-seq data for
the reference-based transcript assembly and reference-free
de novo transcript assembly, respectively. A detailed de-
scription of this procedure is listed in Additional file 3:
Supplementary Methods.
Transcript contigs mapping
The transcript contigs produced by Trinity were mapped
to the human genome (hg19) using GMAP [19] (version
2011-10-07) with the following parameters: (-A microexon-
spliceprob 0.95 -f 1). Unambiguously and uniquely aligned
transcript contigs were further required to meet the min-
imal identity cutoff >0.95, and the coverage cutoff >0.95.
After merging overlapping mapped contigs, 92,705 separate
contig clusters remained. The “known” and “novel” contig
clusters classification was based on Ensembl gene annota-
tion (version 64) [20]: assembled contig clusters that over-
lapped with at least one annotated transcript by at least one
nucleotide were classified as “known”, the remaining contig
clusters were classified as “novel”.
To identify novel contig clusters that were missing be-
cause of the incompleteness of the current human gen-
ome (hg19), we first collected contig clusters that couldnot be mapped to the human genome, using a relaxed
mapping cutoff (mapping minimal identity >0.8, cover-
age >0.5), and further mapped them to four non-human
genomes (chimpanzee, orangutan, rhesus macaque and
mouse) using GMAP with an additional parameter
(–cross-species). This resulted in 368 transcript contigs
that could be aligned to at least one non-human genome
(minimal identify >0.8, coverage >0.8), covering a total
length of 146,035 nt. Putative protein-coding genes and
exons were obtained by overlapping the 368 transcript
contigs with annotations from the four non-human
genomes.
Novel elements of annotated transcripts
Novel transcribed elements of annotated genes, includ-
ing novel internal exons, novel splicing donor & ac-
ceptor splicing sites and novel 5′UTR & 3′UTR
extensions, were defined based on the assembled contig
clusters overlapping with at least one transcript, anno-
tated by the Ensembl database (version 64). Novel in-
ternal exons were defined based on the assembled contig
clusters sharing at least one exon of annotated tran-
scripts, and were further required to fully reside within
the intron region of this annotated transcript. Novel
donor and acceptor splice sites were required to share
one boundary with an internal exon of an annotated
transcript and containing the canonical donor/acceptor
splicing sequence (GT-AG) at the novel splice boundary.
Novel 5′UTR & 3′UTR extensions were required to
share at least one exon with annotated transcripts and
each extended region was at least 100 nt long.
The expression levels of novel and known elements of
annotated transcripts was estimated using RSEM: a soft-
ware package for estimating gene and isoform expression
levels from RNA-Seq data with the EM algorithm [4].
Novel elements validation
Novel internal exons, as well as novel donor and acceptor
splice sites, were further validated using other transcript
assembly algorithms: Oases or Cufflinks. Novel 5′UTR
extensions were validated by the presence of a H3K4me3
modification peak within a 2 kb region from the novel 5′
end of the transcript. Novel 3′UTR extensions were vali-
dated by the presence of sequence reads corresponding
to transcripts’ polyA tails within a 2 kb region from the
novel 3′end of the transcript. A detailed description of this
procedure is listed in Additional file 3: Supplementary
Methods.
General properties of novel transcript contigs
The expression levels of novel transcript contigs were
quantified as Reads Per Kilobase per Million of the total
mapped RNA-seq reads (RPKM). The coding potential
of novel transcript contigs was estimated using the CPC
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ceptor site splice signals within novel transcript contigs
was identified using GT-AG motifs. Exon conservation
was estimated using phastCons17way based on 17 verte-
brate species’ genomes data from UCSC [50]. For each
exon, we used the average of all nucleotides’ phastCon
scores to represent its conservation. We further required
more than 80% of exon’s nucleotides to have a valid
phastCon score. The same sequence conservation calcu-
lation procedure was used for another two genome
sequence categories: (i) randomly selected intergenic re-
gions and (ii) annotated lncRNAs. The tissue specificity
of transcript expression was estimated using RNA-seq
data from Human Body map [4]. To increase tissue
coverage, two deep sequencing datasets with comparable
sequencing coverage (fetal brain and fetal liver [51])
were combined with Human Body map data, resulting in
sequencing data from a total of 19 human tissues. All
novel transcript contigs, with a mean expression >0.1
RPKM across tested tissues, were classified into three
categories: (i) tissue-specific, (ii) tissue-selective and (iii)
ubiquitously expressed. Detailed classification method
description is listed in Additional file 3: Supplementary
Methods. The nuclear and cytoplasmic localization pref-
erence of novel transcripts was estimated using RNA-
Seq data from SK-N-SH cells (human neuroblastoma cell
line, GSE30567) from ENCODE/Cold Spring Harbor
labs. To analyze temporal expression patterns of novel
transcripts in human PFC development, novel transcript
expression levels were quantified separately in each of
14 human PFC samples with different ages. Age-related
novel lncRNAs were identified using a polynomial
regression-based age test [52] at p < 0.01 under FDR 2%.
The p-value cutoff and corresponding FDR was calcu-
lated by 1,000 permutations of sample age labels.
Detailed description of FDR estimation procedure is
listed in Additional file 3: Supplementary Methods. The
K-means clustering algorithm was used to classify age-
related novel and annotated transcripts into 12 clusters.
Within each cluster, Fisher’s exact test was used to cal-
culate the enrichment of novel transcripts compared to
all age-related novel and annotated transcripts. Fisher’s
exact test p < 0.05 after Bonferroni correction was con-
sidered as significant.
Expression correlation of sense/antisense gene pairs
Sense/antisense gene pairs were defined based on three
types of overlapping scenarios: (1) annotated in Ensembl
annotation; (2) just like the first type, except that the
overlap comes from assembled contigs that went beyond
Ensembl annotation; (3) splicing-based overlap supported
by novel junction reads. More specifically: in (1), anno-
tated overlap was identified by searching overlapped genes
from different strands within Ensembl annotation; in (2) ifan assembled contig, representing genuine extension of
one gene (at 5′ or 3′ end), overlapped with another gene
on different strand, it was considered as a sense/antisense
pair. In many cases, type (2) represents further extension
for overlapping gene pairs already annotated within
Ensembl (Additional file 7: Table S4). In (3), novel junc-
tions reads supporting overlapping gene pairs were identi-
fied by PalMapper [49] and Tophat [53] with default
parameters. We only used novel junction reads that were
supported by both algorithms, and further required that
the junction reads should match annotated splice sites
within one gene. Note that the three approaches used to
define sense/antisense pairs are not mutually exclusive
(Additional file 7: Table S4).
For every gene, we required a mean expression > =0.1
RPKM. Pairs involved in complex genomic loci, with
more than two genes having the same overlapping pat-
tern in multiple cases (tail-to-tail or head-to-head), were
removed from further analysis.
Expression correlation for each overlapping sense/anti-
sense gene pairs during postnatal development was
measured by Pearson correlation coefficient, and non-
overlapping gene pairs (closest in the genome in terms
of location, and from different strands as for overlapping
ones) were used as control to check the potential influ-
ence of antisense transcription. Further, the significance
of this influence was assessed by sampling 100 times
from the control in order to obtain the same number of
gene pairs as overlapping ones.
Novel transcript classification based on genomic context
Novel transcripts located outside of annotated gene re-
gions were classified into four categories, based on their
location with respect to the nearest annotated gene:
upstream-sense, downstream-sense, upstream-antisense
and downstream-antisense. The distance cutoff used to
identify novel transcript – annotated gene pairs was defined
using random transcript pairs distance distribution, calcu-
lated by 1,000 permutations of novel transcript loci along
each chromosome (for each permutation, keeping the same
number of novel transcripts on each strand of each
chromosome). A detailed description of the cutoff selection
procedure is listed in Additional file 3: Supplementary
Methods. We used a Wilcoxon rank test to compare the
observed distributions and each of the 200 simulated
distributions of the correlation coefficients to determine
how many of them pass the statistical significance cut-
off. Specifically, for each permutation, we randomized
the relationship between novel contig clusters and
nearby protein-coding genes and estimated the statis-
tical significance of the correlation distribution differ-
ence using Wilcoxon rank test. We found significantly
stronger positive correlations for the actual data when
compared to each of the 200 simulated distributions, for
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lncRNA in the upstream-sense, downstream-sense and
upstream-antisense categories (Wilcoxon rank test,
p < 0.05).
Divergent transcription at promoters associated with
upstream-antisense category
The divergent transcription from promoters was esti-
mated by deepCAGE data from FANTOM4 [9]. Only
deepCAGE data from brain tissues was used. To define
the divergent transcription features specific to the pro-
moters that were associated with novel transcripts from
the upstream-antisense category, unidirectional and
known bidirectional expressed annotated genes were
used as background. The criteria to select unidirectional,
known bidirectional promoters and novel bidirectional
promoters were as follows: for known bidirectional pro-
moters and novel bidirectional promoters, genes were
required to form head-to-head gene pairs within the re-
gion of 2 kb from TSS. The choice of 2 kb as a distance
cutoff to define bidirectional promoters in our study was
dictated by artificial transcript shortening at the 5′-end
as a result of the de novo assembly procedure. Specific-
ally, the Illumina RNA-sequencing protocol used in our
study includes a polyA enrichment procedure employing
polyT primers. It results in a preferential coverage of the
transcripts’ 3′ regions where the polyA tail is located
leaving the 5′ part underrepresented and frequently in-
complete, especially in cases of detectable RNA degrad-
ation. To assess the extent of this coverage bias, we
tested distances between gene pairs, defined based on
the de novo assembly results, for 745 known bidirec-
tional promoters containing gene pairs annotated to be
within 1 kb distance from one another. We found that
for 184 (24.7%) of these 745 bidirectional promoters the
distance was greater than 1 kb when based on de novo
assembly results (Additional file 5: Figure S10b). Thus,
when using 1 kb as a cutoff, close to 25% of the known
bidirectional promoters will be missed. By contrast,
when using a 2 kb distance cutoff, 91.8% of them are
retained. Importantly, the false positive rate of the bidir-
ectional promoter definition only increased to a total of
7.5% when changing from 1 kb to 2 kb distance cutoff.
Using 1 kb instead of 2 kb cutoff did not alter results
(Additional file 5: Figure S10). For unidirectional pro-
moters, genes were required to have no annotated tran-
scripts, or novel transcript contigs identified in this
study, within the 5 kb region upstream of their TSS. The
promoters defined as showing divergent transcription
were required to have at least one CAGE tag on each
strand. Unidirectional promoters were required to have
at least two CAGE tags at the annotated gene’s strand,
and zero tags at the opposite strand. The promoters
containing no CAGE tags were excluded from analysis.Fisher’s exact test was used to calculate the divergent
transcription feature enrichment.
Properties of genes associated with novel upstream
antisense transcripts
The protein-coding genes that showed significant positive
correlation with the expression of upstream antisense
lncRNAs (Pearson correlation p < 0.05 after Benjamini-
Hochberg correction) were selected for functional feature
analysis. Functional enrichment was conducted using a
hypergeometric test implemented in the Genetrail package
[54]. Functional terms with p < 0.05 after Benjamini-
Hochberg correction were considered as significant.
Protein-coding genes with mean expression >0.1RPKM in
human PFC data were used as a background. Enriched
GO terms were visualized after term redundancy reduc-
tion using REVIGO [32]. The same functional enrichment
analysis procedure was applied to protein-coding genes
associated with novel transcripts from the other three cat-
egories, as well as protein-coding genes associated with
novel upstream antisense transcripts but not showing
positive correlation.
H3K4me3 modification enrichment analysis between
neurons and non-neuronal cells from human PFC was
conducted using ChIPDiff [55]. H3K4me3 modification
data from neurons and non-neuronal cells of human
PFC was downloaded from [33]. The regions with more
than two-fold higher H3K4me3 modification signals in
neurons than in non-neuronal cells were considered as
regions preferentially expressed in neurons (assigned
with a “N” flag). The regions with opposite modification
signal patterns were considered as regions preferentially
expressed in non-neural cells (assigned with a “non-N”
flag). The significance was assessed by 1,000 permuta-
tions of N and non-N flag labels.
The list of mouse genes with known cell-type-specific
expression patterns was downloaded from [34]. Human
orthologs were determined using Biomart from Ensembl
[20]. Fisher’s exact test was used to test the enrichment
significance, and p < 0.05 after Bonferroni correction was
considered as significant.
Analysis of the DNA sequence and epigenetic features of
uni-, known and novel bidirectional promoters
Uni-, known and novel bidirectional promoters were de-
fined as described above. Three DNA sequence features
(GC content, regulatory potential, sequence conserva-
tion) and two epigenetic features (H3K4me3 modifica-
tion profile and DNA methylation status) were explored.
Specifically, GC content was measured as the G +C per-
centage of the promoter region. Regulatory potential was
estimated using the Regulatory Potential (RP) Scores down-
loaded from UCSC [50]. RP Scores are a computational
tool to aid in the identification of putative regulatory sites
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the average RP score to represent its Regulatory Potential.
We further required more than 80% of promoter nucleo-
tides to have a valid RP score. Promoter region conserva-
tion was estimated using phastCon scores, based on 17
vertebrate species genome data and using the same ap-
proach as for the estimation of novel contig conservation.
The differences with respect to each of the three DNA fea-
tures among these three promoter types were tested using
the Kolmogorov–Smirnov test.
H3K4me3 modification data from one adult human
PFC was downloaded from [39]. H3K4me3 modification
and input control data from rhesus macaque PFC was
downloaded from [40]. H3K4me3 modification and in-
put control data from Hela cells was downloaded from
[41]. H3K4me3 modification density differences were
tested using the Wilcoxon signed-rank test. For DNA
methylation data, the DNA methylation status of the hu-
man PFC, measured by MeDIP sequencing (Methylated
DNA Immunoprecipitation Sequencing), was down-
loaded from [39]. The DNA methylation level differences
were tested using Wilcoxon signed-rank test.
The RNA-Seq data of PABPN1 knockdown and con-
trol experiments was downloaded from SRP015926 [48].
We adopted the same method used in [48] for expres-
sion quantification of known protein-coding genes,
known lncRNAs and novel lncRNAs.
Additionally we compared the DNA sequence com-
position and epigenetic features of NBiPs and lncKBiPs
that are formed by protein-code genes and known
lncRNA pairs. Except for the shape of the H3K4me3
modification profile, significant differences for the other
features can also be detected for these two promoter
types. At the same time, the sequence and epigenetic
properties of lncKBiPs more closely resemble known
bidirectional promoters that are formed by pairs of
protein-coding genes (pcKBiPs). Besides the sequence
and epigenetic features, the effect of a PABPN1 knock-
down on lncRNA associated with NBiPs was different
compared to the effect seen for the known lncRNA and
protein-coding genes that are associated with lncKBiPs
and pcKBiPs (Additional file 5: Figure S8).
Enriched transcription factor binding site detection in
novel bidirectional promoter (NBiP) regions
Transcription factor binding sites (TFBSs) located within
NBiP and KBiP regions were predicted using the
MATCH algorithm based on TRANSFAC Release 11
[56]. To minimize false positive matches, the matrix file
vertebrate_non_redundant_minFP.prf was used for TFBS
prediction. Enriched TFBS in NBiP regions were identi-
fied by Fisher’s exact test, using KBiP regions as a back-
ground. Significantly enriched TFBS had to satisfy the
following criteria: a) Benjamini-Hochberg adjusted p-value < 0.05; b) Fisher’s exact test odds ratio > 1.3. The
background distribution of TFBS along NBiP was esti-
mated by dinucleotide shuffle of NBiP sequences. Specif-
ically, NBiP sequences were subjected to dinucleotide
shuffle 1,000 times and the MATCH algorithm was ap-
plied to the shuffled sequences. CoCiter [37] was used to
check the significance of association between transcrip-
tion factors enriched in NBiP and KBiP, with the terms
“neuron” and “neural”, respectively.Additional files
Additional file 1: Table S1. Containing sample information.
Additional file 2: Table S2. Containing RNA-seq data mapping statistics.
Additional file 3: Supplementary methods. This file contains
additional detailed methods description.
Additional file 4: Supplementary data 1 containing three tables.
Table 1. Contains information about all novel transcripts identified in this
study. Table 2. Contains a list of 273 novel transcripts/protein-coding
genes pairs originating at NBiPs and showing significantly positive
expression correlation in PFC development. Table 3. Contains NBiPs
identified in this study.
Additional file 5: Figure S1. Shows major expression patterns of
protein-coding genes and novel lncRNAs measured across human
postnatal PFC development. Figure S2. Shows relative position and
count distribution of assembled antisense transcripts within the sense
region of annotated protein-coding genes. Figure S3. Shows expression
correlation across postnatal PFC development of overlapping tail-to-tail
sense/antisense gene pairs from different types of overlapping scenarios.
Figure S4. Shows expression correlation across postnatal PFC development
of overlapping head-to-head sense/antisense gene pairs from different
types of overlapping scenarios. Figure S5. Shows divergent transcription at
different promoter types. Figure S6. Shows H3K4me3 modification profiles
at three promoter types. Figure S7. Shows H3K4me3 input/control data
profiles at three promoter types. Figure S8. Shows the sequence and
epigenetic features of four promoter types, including bidirectional
promoters that are formed by known lncRNA and protein-coding gene
pairs. Figure S9. Shows the correlation between the expression of protein-
coding genes located on the sense and antisense strands. Figure S10.
Shows the sequence and epigenetic features of three promoter types at a
1 kb distance cutoff.
Additional file 6: Table S3. Shows novel lncRNAs and known protein-
coding gene enrichment in 12 clusters.
Additional file 7: Table S4. Shows number of sense/antisense gene
pairs based on different annotation sources.
Additional file 8: Table S5. Shows CAGE tag distribution on forward
and reverse strands for three promoter types.
Additional file 9: Table S6. Contains 3 tables. Table 1. Shows GO
functions enriched in genes associated with novel upstream antisense
lncRNAs based on Trinity assembly. Table 2. Shows GO functions
enriched in genes associated with novel upstream antisense lncRNAs
based on Cufflinks assembly. Table 3. Shows GO functions enriched in
genes associated with novel upstream antisense lncRNAs based on
intersection of Trinity and Cufflinks assembly.
Additional file 10: Table S7. Contains 2 tables. Table 1. Lists over-
represented GO functions for genes associated with KBiPs. Table 2. Lists
under-represented GO functions for genes associated with KBiPs.
Additional file 11: Table S8. Contains 2 tables. Table 1. Lists over-
represented GO functions for genes associated with UniPs. Table 2. Lists
under-represented GO functions for genes associated with UniPs.
Additional file 12: Table S9. Lists transcription factors showing
binding site overrepresentation in NBiP.
Hu et al. BMC Genomics 2014, 15:457 Page 15 of 16
http://www.biomedcentral.com/1471-2164/15/457Additional file 13: Table S10. Lists Transcription factors showing
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Additional file 14: Table S11. Shows strand distribution of uniquely
mapped reads.
Additional file 15: Table S12. Shows RNA-seq coverage at splice site
sequences corresponding to sense/antisense splice junctions.
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